Device Trial Radar · NCT07186725
Home-based Under Mattress Monitor for OSA
Last checked: Nov 19, 2026Latest source record: Feb 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Jan 7, 2026
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Isabel Moreno HayAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- American Academy of Dental Sleep Medicine
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to evaluate the effectiveness of the under-mattress monitoring device to aid in the titration process of a mandibular advancement device (MAD) for the management of obstructive sleep apnea (OSA). A secondary aim is to evaluate changes in subjective OSA symptoms and patient's satisfaction with MAD. A third aim is to analyze if there are differences between the sleep parameters recorded by the under-mattress monitor between responders and non-responders to MAD therapy.
Conditions
- Obstructive Sleep Apnea (OSAS)
- Obstructive Sleep Apnea (SAOS)
Interventions
Under-mattress monitorDevice
the under-mattress monitor will be used in conjunction with the Alice NightOne at the beginning and end of the study, in addition, the under-mattress monitor will be used daily during sleep with the intraoral device in situ
level 3 Home Sleep Apnea TestDevice
Home sleep apnea test with Alice NightOne will be used for one day during sleep at the beginning and end of the study in conjunction with the Sleeptracker AI and the intraoral device.
Mandibular Advancement Device (MAD)Device
CAD-CAM, US Food and Drug Administration (FDA)-approved MAD, duo-bloc, customized, titratable sleep appliance. Participants will return every 2 weeks to the Orofacial Pain (OFP) clinic to progressively titrate the MAD advancement as needed until the under-mattress monitor scores an AHI \< 5
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in apnea-hypopnea index (AHI).Time frame: Baseline and post-intervention (approximately 12 weeks)
- Change in minimum oxygen desaturation levelTime frame: Baseline and post-intervention (approximately 12 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Kentucky
Lexington, Kentucky · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.